Sporadic early-onset colorectal cancer is a specific sub-type of cancer: a morphological, molecular and genetics study.
Sporadic early onset colorectal carcinoma (EOCRC) which has by definition no identified hereditary predisposition is a growing problem that remains poorly understood. Molecular analysis could improve identification of distinct sub-types of colorectal cancers (CRC) with therapeutic implications and t...
Guardado en:
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bf92d2b8c27747fdb0da0a0e0d2c6b9a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:bf92d2b8c27747fdb0da0a0e0d2c6b9a |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:bf92d2b8c27747fdb0da0a0e0d2c6b9a2021-11-25T06:06:26ZSporadic early-onset colorectal cancer is a specific sub-type of cancer: a morphological, molecular and genetics study.1932-620310.1371/journal.pone.0103159https://doaj.org/article/bf92d2b8c27747fdb0da0a0e0d2c6b9a2014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25083765/?tool=EBIhttps://doaj.org/toc/1932-6203Sporadic early onset colorectal carcinoma (EOCRC) which has by definition no identified hereditary predisposition is a growing problem that remains poorly understood. Molecular analysis could improve identification of distinct sub-types of colorectal cancers (CRC) with therapeutic implications and thus can help establish that sporadic EOCRC is a distinct entity. From 954 patients resected for CRC at our institution, 98 patients were selected. Patients aged 45-60 years were excluded to help define "young" and "old" groups. Thirty-nine cases of sporadic EOCRC (patients ≤ 45 years with microsatellite stable tumors) were compared to both microsatellite stable tumors from older patients (36 cases, patients>60 years) and to groups of patients with microsatellite instability. Each group was tested for TP53, KRAS, BRAF, PIK3CA mutations and the presence of a methylator phenotype. Gene expression profiles were also used for pathway analysis. Compared to microsatellite stable CRC from old patients, sporadic EOCRC were characterized by distal location, frequent synchronous metastases and infrequent synchronous adenomas but did not have specific morphological characteristics. A familial history of CRC was more common in sporadic EOCRC patients despite a lack of identified hereditary conditions (p = 0.013). Genetic studies also showed the absence of BRAF mutations (p = 0.022) and the methylator phenotype (p = 0.005) in sporadic EOCRC compared to older patients. Gene expression analysis implicated key pathways such as Wnt/beta catenin, MAP Kinase, growth factor signaling (EGFR, HGF, PDGF) and the TNFR1 pathway in sporadic EOCRC. Wnt/beta catenin signaling activation was confirmed by aberrant nuclear beta catenin immunostaining (p = 0.01). This study strongly suggests that sporadic EOCRC is a distinct clinico-molecular entity presenting as a distal and aggressive disease associated with chromosome instability. Furthermore, several signaling pathways including the TNFR1 pathway have been identified as potential biomarkers for both the diagnosis and treatment of this disease.Sylvain KirzinLaetitia MarisaRosine GuimbaudAurélien De ReyniesMichèle LegrainPierre Laurent-PuigPierre CordelierBernard PradèreDelphine BonnetFabienne MeggettoGuillaume PortierPierre BroussetJanick SelvesPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 8, p e103159 (2014) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Sylvain Kirzin Laetitia Marisa Rosine Guimbaud Aurélien De Reynies Michèle Legrain Pierre Laurent-Puig Pierre Cordelier Bernard Pradère Delphine Bonnet Fabienne Meggetto Guillaume Portier Pierre Brousset Janick Selves Sporadic early-onset colorectal cancer is a specific sub-type of cancer: a morphological, molecular and genetics study. |
description |
Sporadic early onset colorectal carcinoma (EOCRC) which has by definition no identified hereditary predisposition is a growing problem that remains poorly understood. Molecular analysis could improve identification of distinct sub-types of colorectal cancers (CRC) with therapeutic implications and thus can help establish that sporadic EOCRC is a distinct entity. From 954 patients resected for CRC at our institution, 98 patients were selected. Patients aged 45-60 years were excluded to help define "young" and "old" groups. Thirty-nine cases of sporadic EOCRC (patients ≤ 45 years with microsatellite stable tumors) were compared to both microsatellite stable tumors from older patients (36 cases, patients>60 years) and to groups of patients with microsatellite instability. Each group was tested for TP53, KRAS, BRAF, PIK3CA mutations and the presence of a methylator phenotype. Gene expression profiles were also used for pathway analysis. Compared to microsatellite stable CRC from old patients, sporadic EOCRC were characterized by distal location, frequent synchronous metastases and infrequent synchronous adenomas but did not have specific morphological characteristics. A familial history of CRC was more common in sporadic EOCRC patients despite a lack of identified hereditary conditions (p = 0.013). Genetic studies also showed the absence of BRAF mutations (p = 0.022) and the methylator phenotype (p = 0.005) in sporadic EOCRC compared to older patients. Gene expression analysis implicated key pathways such as Wnt/beta catenin, MAP Kinase, growth factor signaling (EGFR, HGF, PDGF) and the TNFR1 pathway in sporadic EOCRC. Wnt/beta catenin signaling activation was confirmed by aberrant nuclear beta catenin immunostaining (p = 0.01). This study strongly suggests that sporadic EOCRC is a distinct clinico-molecular entity presenting as a distal and aggressive disease associated with chromosome instability. Furthermore, several signaling pathways including the TNFR1 pathway have been identified as potential biomarkers for both the diagnosis and treatment of this disease. |
format |
article |
author |
Sylvain Kirzin Laetitia Marisa Rosine Guimbaud Aurélien De Reynies Michèle Legrain Pierre Laurent-Puig Pierre Cordelier Bernard Pradère Delphine Bonnet Fabienne Meggetto Guillaume Portier Pierre Brousset Janick Selves |
author_facet |
Sylvain Kirzin Laetitia Marisa Rosine Guimbaud Aurélien De Reynies Michèle Legrain Pierre Laurent-Puig Pierre Cordelier Bernard Pradère Delphine Bonnet Fabienne Meggetto Guillaume Portier Pierre Brousset Janick Selves |
author_sort |
Sylvain Kirzin |
title |
Sporadic early-onset colorectal cancer is a specific sub-type of cancer: a morphological, molecular and genetics study. |
title_short |
Sporadic early-onset colorectal cancer is a specific sub-type of cancer: a morphological, molecular and genetics study. |
title_full |
Sporadic early-onset colorectal cancer is a specific sub-type of cancer: a morphological, molecular and genetics study. |
title_fullStr |
Sporadic early-onset colorectal cancer is a specific sub-type of cancer: a morphological, molecular and genetics study. |
title_full_unstemmed |
Sporadic early-onset colorectal cancer is a specific sub-type of cancer: a morphological, molecular and genetics study. |
title_sort |
sporadic early-onset colorectal cancer is a specific sub-type of cancer: a morphological, molecular and genetics study. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2014 |
url |
https://doaj.org/article/bf92d2b8c27747fdb0da0a0e0d2c6b9a |
work_keys_str_mv |
AT sylvainkirzin sporadicearlyonsetcolorectalcancerisaspecificsubtypeofcanceramorphologicalmolecularandgeneticsstudy AT laetitiamarisa sporadicearlyonsetcolorectalcancerisaspecificsubtypeofcanceramorphologicalmolecularandgeneticsstudy AT rosineguimbaud sporadicearlyonsetcolorectalcancerisaspecificsubtypeofcanceramorphologicalmolecularandgeneticsstudy AT aureliendereynies sporadicearlyonsetcolorectalcancerisaspecificsubtypeofcanceramorphologicalmolecularandgeneticsstudy AT michelelegrain sporadicearlyonsetcolorectalcancerisaspecificsubtypeofcanceramorphologicalmolecularandgeneticsstudy AT pierrelaurentpuig sporadicearlyonsetcolorectalcancerisaspecificsubtypeofcanceramorphologicalmolecularandgeneticsstudy AT pierrecordelier sporadicearlyonsetcolorectalcancerisaspecificsubtypeofcanceramorphologicalmolecularandgeneticsstudy AT bernardpradere sporadicearlyonsetcolorectalcancerisaspecificsubtypeofcanceramorphologicalmolecularandgeneticsstudy AT delphinebonnet sporadicearlyonsetcolorectalcancerisaspecificsubtypeofcanceramorphologicalmolecularandgeneticsstudy AT fabiennemeggetto sporadicearlyonsetcolorectalcancerisaspecificsubtypeofcanceramorphologicalmolecularandgeneticsstudy AT guillaumeportier sporadicearlyonsetcolorectalcancerisaspecificsubtypeofcanceramorphologicalmolecularandgeneticsstudy AT pierrebrousset sporadicearlyonsetcolorectalcancerisaspecificsubtypeofcanceramorphologicalmolecularandgeneticsstudy AT janickselves sporadicearlyonsetcolorectalcancerisaspecificsubtypeofcanceramorphologicalmolecularandgeneticsstudy |
_version_ |
1718414188258263040 |